Back to Stakeholders
Rose Hill Life Sciences is a North American psychedelic life sciences company that supplies research-grade Psilocybe cubensis biomass and sponsors clinical trials, including the PHATHOM study testing psilocybin combined with physical therapy to restore motor function in stroke patients; it also collaborates with Johns Hopkins, the University of Guelph, and the Canadian Centre for Psychedelic Science, and has operated a psilocybin mushroom cultivation facility since 2015.
Quick Facts
- Type
- Private Biotech
- HQ
- Canada
- Website
- Visit